Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Panel Backs Saphris To Treat Schizophrenia,Bipolar
FDA Panel Backs Saphris To Treat Schizophrenia,Bipolar
FDA Panel Backs Saphris To Treat Schizophrenia,Bipolar
Submitted by
admin
on July 30, 2009 - 3:25pm
Source:
WSJ Online
News Tags:
Saphris
schizophrenia
bipolar disorder
FDA
Schering Plough
Headline:
FDA Panel Backs Saphris To Treat Schizophrenia,Bipolar
Do Not Allow Advertisers to Use My Personal information
